Search ADUS
Addus HomeCare Corp
Nasdaq · CIK 1468328
Last close111.27
Daily change-0.43 (-0.38%)
10 Years gain+327.47%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ADUS · STANDARD
SIC 8082 · Services-Home Health Care Services · Fiscal year end 1231
Fundamental
51.0Momentum
53.3Acceleration
53.3Confidence
86.0Annual Revenue17
Quarterly Revenue74
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth19.4 / 25
Quality17.0 / 25
Capital Efficiency6.1 / 20
Balance Sheet6.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.3194 percentage points.
Operating leverageOperating margin improved by 0.6632 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM21.55%OK
Revenue CAGR 3Y14.36%OK
Gross Margin32.22%OK
Operating Margin9.56%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC9%OK
Incremental Operating Margin 3Y14.69%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y0.88%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.42B | $461.87M | $138.62M | $111.51M | $103.79M | 32.47% | 9.74% | 7.3% | 9.09% | 18.39M |
| 2025 FY Dec 31, 2024 | $1.15B | $375.02M | $102.69M | $116.43M | $110.38M | 32.48% | 8.89% | 9.56% | 8.2% | 17.38M |
| 2025 FY Dec 31, 2023 | $1.06B | $339.88M | $90.96M | $112.25M | $102.79M | 32.1% | 8.59% | 9.71% | 9.63% | 16.31M |
| 2024 FY Dec 31, 2022 | $951.12M | $299.74M | $68.74M | $105.11M | $96.81M | 31.51% | 7.23% | 10.18% | 8.02% | 16.18M |
| 2023 FY Dec 31, 2021 | $864.50M | $269.85M | $65.94M | $39.49M | $34.84M | 31.21% | 7.63% | 4.03% | 8.25% | 16.06M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.45B | sum latest 4 fiscal quarters Revenue | OK | 0001437749-26-025678, 0001437749-25-033041 |
| Revenue Growth TTM | 21.55% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001437749-26-025678, 0001437749-25-033041 |
| Revenue CAGR 3Y | 14.36% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001437749-26-005352 |
| Revenue CAGR 5Y | 13.22% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001437749-26-005352 |
| Gross Profit CAGR 3Y | 15.5% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001437749-26-005352 |
| Operating Income Growth | 30.62% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001437749-26-025678, 0001437749-25-033041 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 32.22% | Gross Profit / Revenue | OK | 0001437749-26-025678, 0001437749-25-033041 |
| Operating Margin | 9.56% | Operating Income / Revenue | OK | 0001437749-26-025678, 0001437749-25-033041 |
| ROIC | 9% | NOPAT / Average Invested Capital | OK | 0001437749-26-025678, 0001437749-25-033041 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001437749-26-025678 |
| Current Ratio | 1.69x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0x | (Cash + Short-term Investments) / Total Debt | OK | derived |
| Revenue per Diluted Share | $78.65 | Revenue / Diluted Shares | OK | 0001437749-26-025678, 0001437749-25-033041 |